Cobo Marcinsider trades
In SEC Form 4 filings, Cobo Marc is listed as Principal Accounting Officer of BridgeBio Oncology Therapeutics, Inc. (BBOT). Cobo Marc reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 23.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| BBOTBridgeBio Oncology Therapeutics, Inc. | Principal Accounting Officer | 5 | Oct 23 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-14
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| BBOTBridgeBio Oncology Therapeutics, Inc. | Oct 21 | Oct 23 | F | 203 | $2.68 | $544 | 13,812 | No | Form 4 |
| BBOTBridgeBio Oncology Therapeutics, Inc. | Oct 1 | Oct 5 | F | 126 | $3.94 | $496 | 14,015 | No | Form 4 |
| BBOTBridgeBio Oncology Therapeutics, Inc. | Sep 10 | Sep 14 | A | 9,038 | $0.00 | $0 | 14,344 | No | Form 4 |
| BBOTBridgeBio Oncology Therapeutics, Inc. | Sep 10 | Sep 14 | F | 203 | $5.52 | $1,121 | 14,141 | No | Form 4 |
| BBOTBridgeBio Oncology Therapeutics, Inc. | Sep 10 | Sep 14 | A · derivative | 43,700 | $5.52 | $241,224 | 43,700 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.